Management Team

Management Team

Daniel OConnor
DANIEL J. O’CONNOR
CEO & DIRECTOR
Mr. O’Connor is the Chief Executive Officer of OncoSec Medical, Inc., a biopharmaceutical company developing intratumoral cancer immunotherapies
>> Read Full Bio
c_twitty
CHRISTOPHER G. TWITTY, PHD
CHIEF SCIENTIFIC OFFICER
Dr. Twitty brings over 20 years of experience in tumor immunology and cancer immunotherapy including the discovery and development of OncoSec’s leading clinical immune monitoring and biomarker program.
>> Read Full Bio
Bonstein
SARA BONSTEIN, MBA
CHIEF FINANCIAL OFFICER & CHIEF OPERATING OFFICER
Ms. Bonstein brings more than 15 years of operational and financial leadership in the life sciences industry with Advaxis, Inc., Eli Lilly & Company, ImClone Systems, and Johnson & Johnson.
>> Read Full Bio
Kellie_m-3
KELLIE MALLOY FOERTER
CHIEF CLINICAL DEVELOPMENT OFFICER 
Ms. Malloy Foerter brings nearly thirty years of experience in clinical research with Syneos Health, inVentiv Health (previously PharmaNet), and Covance. 
>> Read Full Bio
kier-photo-1
KEIR LOIACONO
GENERAL COUNSEL, VICE PRESIDENT CORPORATE DEVELOPMENT, CHIEF COMPLIANCE OFFICER
Mr. Loiacono brings more than 17 years of success across the life sciences and medical device industries, having held commercial, legal and business roles. 
>> Read Full Bio
Robert-Ashworth-2
ROBERT W. ASHWORTH, PHD
SENIOR VICE PRESIDENT, REGULATORY QUALITY AND CMC
With more than 35 years of experience in the pharmaceutical industry, Dr. Ashworth is well-versed in drug development and global regulatory strategies and has made significant contributions to the FDA approval of 12 new drugs. 
>> Read Full Bio
John-Rodriquez_sm
JOHN RODRIGUEZ
VICE PRESIDENT, PRODUCT ENGINEERING
Mr. Rodriguez is a leader in product development with over 30 years of experience heading teams in the design, development and manufacture of products for the biomedical industry. 
>> Read Full Bio

Board of Directors

DANIEL J. O’CONNOR
CEO & DIRECTOR
Mr. O’Connor is the Chief Executive Officer of OncoSec Medical, Inc., a biopharmaceutical company developing intratumoral cancer immunotherapies.
>> Read Full Bio
AVTAR DHILLON, M.D.
CO-FOUNDER / CHAIRMAN
Founder of OncoSec Medical, Inc. and Vitality Biopharma, Inc., Avtar S. Dhillon is a businessperson who has been the head of 9 different companies.
>> Read Full Bio
PUNIT DHILLON
CO-FOUNDER / DIRECTOR
Mr. Dhillon is the Co-Founder of OncoSec Medical, Inc., a biopharmaceutical company developing its advanced-stage immunotherapy to treat solid tumors.
>> Read Full Bio
MARGARET R. DALESANDRO, PHD
DIRECTOR
Dr. Dalesandro brings more than 25 years of drug development experience in the pharmaceutical, biotechnology and diagnostics industries.
>> Read Full Bio
JOON KIM
DIRECTOR
Joon Kim is a highly accomplished attorney and partner in Lee & Ko’s Corporate, International Litigation and Dispute Resolution, and White Collar Crime Practice Groups. Mr. Kim advises clients, both domestic and international, on a broad range of litigation, dispute-resolution and transactional matters.
>> Read Full Bio
ROBERT E. WARD
DIRECTOR
Mr. Ward is currently the Chief Executive Officer and Chairman of the Board of Eloxx Pharmaceuticals, Inc., roles he has held since December 2017. He was a Director and Chair of the Governance Committee of Akari Therapeutics from October 2016 to August 2018.
>> Read Full Bio
JIM DEMESA, MD, MBA
DIRECTOR
Dr. DeMesa has served as a senior executive with several international pharmaceutical and biotech companies in the areas of corporate management, regulatory affairs, and pre-clinical and clinical pharmaceutical and medical device product development.
>> Read Full Bio

Scientific Advisory Board

RICHARD HELLER, PHD
Dr. Heller has over 25 years of experience in evaluating effects of electric pulses on biological systems. He is recognized as a pioneer on the use of electrotransfer for drug and gene delivery.
>> Read Full Bio
IACOB MATHIESEN, PHD
Dr. Mathiesen has a PhD from University of Oslo, Norway. He was a co-founder of Inovio AS, Norway and inventor on numerous electroporation related patents covering devices and methods for gene based immune therapy.
>> Read Full Bio
SOLDANO FERRONE, MD, PHD
Dr. Ferrone leads a research program focused on the characterization of escape mechanisms deployed by tumor cells to avoid immune-mediated recognition and destruction.
>> Read Full Bio

Clinical Advisory Board

ALAIN ALGAZI M.D. 

Associate Professor, Department of Medicine (Hematology / Oncology), UCSF Program Leader, UCSF Head and Neck Medical Oncology Melanoma Specialist, UCSH Medical Center

ROBERT H.I. ANDTBACKA, M.D., CM, FACS, FRCSC

Associate Professor, Surgical Oncology Department of Surgery University of Utah, Co-Director Melanoma Program, Co-Director Melanoma Clinical Research Program Huntsman Cancer Institute

AXEL HAUSCHILD, M.D.,Ph.D  

Professor of Dermatology, Department of Dermatology, University Hospital Schleswig-Holstein in Kiel, Germany

GEORGINA LONG, BSc, Ph.D., MBBS, FRACP 

Conjoint Medical Director Melanoma Institute Australia, Professor of Melanoma Medical Oncology and Translational Research Melanoma Institute Australia, University of Sydney, Royal North Shore Hospital

PAMELA MUNSTER, M.D. 

Professor, Department of Medicine (Hematology/Oncology), UCSF; Director, Early Phase Clinical Trials Unit, Co-leader of the Center for BRCA Research, and Leader, Experimental Therapeutics Program, UCSF Helen Diller Family Comprehensive Cancer Center

WALTER J URBA, M.D., Ph.D.  

Medical Oncologist; director of cancer research; co-director, Providence Melanoma Program